Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 ... - PR Newswire (press release) PDF Print
PR Newswire (press release)
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel,

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.